White House Defends FDA Halting Use of 2 Innefective Antibody Drugs

Top International News

The White House is defending the FDA’s decision to revoke emergency authorization for the Covid antibody drugs from Regeneron and Eli Lilly.

Credit Bloomberg Quicktake: Now